Literature DB >> 17516489

The suitability of patient-based measures in the field of Parkinson's disease: a systematic review.

Brenda L Den Oudsten1, Guus L Van Heck1, Jolanda De Vries1,2.   

Abstract

The aim of this study is to appraise the suitability of current quality of life (QOL) questionnaires for use in the field of Parkinson's disease (PD). Computerized bibliographic databases were screened for publications from 1960 to December 2006. Predefined selection criteria were used to identify QOL questionnaires in PD studies. Two investigators independently assessed and, subsequently, agreed on a set of multidimensional generic and PD-specific QOL questionnaires. Data were extracted concerning the internal structure, reliability, validity, and responsiveness of the included questionnaires. Sixteen-questionnaires were found, of which 14 questionnaires were included (six generic measures and eight PD-specific). In general, the psychometrics of all the questionnaires were adequately described. Sensitivity to change, however, has been reported for only a limited number of instruments. Almost all included questionnaires used QOL as a keyword, but only two questionnaires fitted the broad QOL definition used in this review. Considering the few "real " QOL questionnaires, we conclude that there is a strong need for such instruments. Copyright 2007 Movement Disorder Society

Entities:  

Mesh:

Year:  2007        PMID: 17516489     DOI: 10.1002/mds.21539

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  18 in total

1.  Factors associated with exercise behavior in people with Parkinson disease.

Authors:  Terry Ellis; James T Cavanaugh; Gammon M Earhart; Matthew P Ford; K Bo Foreman; Lisa Fredman; Jennifer K Boudreau; Leland E Dibble
Journal:  Phys Ther       Date:  2011-10-14

2.  Conceptualizing and prioritizing clinical trial outcomes from the perspectives of people with Parkinson's disease versus health care professionals: a concept mapping study.

Authors:  Catharina Sjödahl Hammarlund; Maria H Nilsson; Markus Idvall; Scott R Rosas; Peter Hagell
Journal:  Qual Life Res       Date:  2014-01-04       Impact factor: 4.147

Review 3.  Cost effectiveness of pharmacotherapies in early Parkinson's disease.

Authors:  Karla M Eggert; Jens P Reese; Wolfgang H Oertel; Richard Dodel
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

4.  Which measures of physical function and motor impairment best predict quality of life in Parkinson's disease?

Authors:  T Ellis; J T Cavanaugh; G M Earhart; M P Ford; K B Foreman; L E Dibble
Journal:  Parkinsonism Relat Disord       Date:  2011-08-05       Impact factor: 4.891

5.  Toward Understanding Ambulatory Activity Decline in Parkinson Disease.

Authors:  James T Cavanaugh; Terry D Ellis; Gammon M Earhart; Matthew P Ford; K Bo Foreman; Leland E Dibble
Journal:  Phys Ther       Date:  2015-04-09

6.  What Should Constitute a Health Related Quality of Life Scale for Parkinson's Disease?

Authors:  Rajeev Aggarwal; Vinay Goyal; Ravindra Mohan Pandey; Nand Kumar; Sumit Singh; Garima Shukla; Madhuri Behari
Journal:  J Clin Diagn Res       Date:  2016-09-01

7.  Iron-related nigral degeneration influences functional topology mediated by striatal dysfunction in Parkinson's disease.

Authors:  Xiaojun Guan; Yuyao Zhang; Hongjiang Wei; Tao Guo; Qiaoling Zeng; Cheng Zhou; Jiaqiu Wang; Ting Gao; Min Xuan; Quanquan Gu; Xiaojun Xu; Peiyu Huang; Jiali Pu; Baorong Zhang; Chunlei Liu; Minming Zhang
Journal:  Neurobiol Aging       Date:  2018-11-22       Impact factor: 4.673

8.  Use of the World Health Organization Quality of Life Assessment Short Version in Mild to Moderate Parkinson Disease.

Authors:  Sarah K Hendred; Erin R Foster
Journal:  Arch Phys Med Rehabil       Date:  2016-06-23       Impact factor: 3.966

9.  Quality of life in a German cohort of Parkinson's patients assessed with three different measures.

Authors:  M Balzer-Geldsetzer; J Klotsche; R Dodel; O Riedel
Journal:  J Neurol       Date:  2018-09-12       Impact factor: 4.849

10.  SF-36 includes less Parkinson Disease (PD)-targeted content but is more responsive to change than two PD-targeted health-related quality of life measures.

Authors:  Carlos A Brown; Eric M Cheng; Ron D Hays; Stefanie D Vassar; Barbara G Vickrey
Journal:  Qual Life Res       Date:  2009-08-28       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.